Bone-cartilage crosstalk: A conversation for understanding osteoarthritis

Bone Research

Volumn 4, Issue , 2016, Pages

  Findlay, David M ^a   Kuliwaba, Julia S ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988489938     PISSN: 20954700     EISSN: 20956231     Source Type: Journal    
DOI: 10.1038/boneres.2016.28     Document Type: Review

References (106)

1. Clark JM, Huber JD. The structure of the human subchondral plate. J Bone Joint Surg Br 1990; 72: 866-873.
2. Duncan H, Jundt J, Riddle JM et al. The tibial subchondral plate. A scanning electron microscopic study. J Bone Joint Surg Am 1987; 69: 1212-1220.
3. Lyons TJ, McClure SF, Stoddart RW et al. The normal human chondroosseous junctional region: evidence for contact of uncalcified cartilage with subchondral bone and marrow spaces. BMC Musculoskelet Disord 2006; 7: 52.
4. Imhof H, Sulzbacher I, Grampp S et al. Subchondral bone and cartilage disease: a rediscovered functional unit. Invest Radiol 2000; 35: 581-588.
5. Kim HK, Bian H, Aya-ay J et al. Hypoxia and hif-1alpha expression in the epiphyseal cartilage following ischemic injury to the immature femoral head. Bone 2009; 45: 280-288.
6. Pan J, Zhou X, Li W et al. In situ measurement of transport between subchondral bone and articular cartilage. J Orthop Res 2009; 27: 1347-1352.
7. Arkill KP, Winlove CP. Solute transport in the deep and calcified zones of articular cartilage. Osteoarthritis Cartilage 2008; 16: 708-714.
8. O'Hara BP, Urban JP, Maroudas A. Influence of cyclic loading on the nutrition of articular cartilage. Ann Rheum Dis 1990; 49: 536-539.
9. Zhang L, Gardiner BS, Smith DW et al. On the role of diffusible binding partners in modulating the transport and concentration of proteins in tissues. J Theor Biol 2010; 263: 20-29.
10. Zhang L, Gardiner BS, Smith DW et al. The effect of cyclic deformation and solute binding on solute transport in cartilage. Arch Biochem Biophys 2007; 457: 47-56.
11. Wang B, Zhou X, Price C et al. Quantifying load-induced solute transport and solute-matrix interaction within the osteocyte lacunarcanalicular system. J Bone Miner Res 2013; 28: 1075-1086.
12. Hwang J, Bae WC, Shieu W et al. Increased hydraulic conductance of human articular cartilage and subchondral bone plate with progression of osteoarthritis. Arthritis Rheum 2008; 58: 3831-3842.
13. Botter SM, van Osch GJ, Clockaerts S et al. Osteoarthritis induction leads to early and temporal subchondral plate porosity in the tibial plateau of mice: an in vivo microfocal computed tomography study. Arthritis Rheum 2011; 63: 2690-2699.
14. Iijima H, Aoyama T, Tajino J et al. Subchondral plate porosity colocalizes with the point of mechanical load during ambulation in a rat knee model of post-traumatic osteoarthritis. Osteoarthritis Cartilage 2016; 24: 354-363.
15. Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 2012; 8: 390-398.
16. Muratovic D, Cicuttini F, Wluka A et al. Bone marrow lesions detected by specific combination of MRI sequences are associated with severity of osteochondral degeneration. Arthritis Res Ther 2016; 18: 54.
17. Lee JH, Dyke JP, Ballon D et al. Subchondral fluid dynamics in a model of osteoarthritis: use of dynamic contrast-enhanced magnetic resonance imaging. Osteoarthritis Cartilage 2009; 17: 1350-1355.
18. Tsai PH, Lee HS, Siow TY et al. Abnormal perfusion in patellofemoral subchondral bone marrow in the rat anterior cruciate ligament transection model of post-traumatic osteoarthritis: a dynamic contrastenhanced magnetic resonance imaging study. Osteoarthritis Cartilage 2016; 24: 129-133.
19. Aaron RK, Dyke JP, Ciombor DM et al. Perfusion abnormalities in subchondral bone associated with marrow edema, osteoarthritis, and avascular necrosis. Ann NY Acad Sci 2007; 1117: 124-137.
20. Sanchez-Adams J, Leddy HA, McNulty AL et al. The mechanobiology of articular cartilage: bearing the burden of osteoarthritis. Curr Rheumatol Rep 2014; 16: 451.
21. Burger EH, Klein-Nulend J. Mechanotransduction in bone-role of the lacuno-canalicular network. FASEB J 1999; 13: S101-S112.
22. Bonewald LF. Mechanosensation and transduction in osteocytes. Bonekey Osteovision 2006; 3: 7-15.
23. Verborgt O, Gibson GJ, Schaffler MB. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 2000; 15: 60-67.
24. Findlay DM. Vascular pathology and osteoarthritis. Rheumatology (Oxford) 2007; 46: 1763-1768.
25. Liu-Bryan R, Terkeltaub R. Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 2015; 11: 35-44.
26. Amin AK, Huntley JS, Simpson AH et al. Chondrocyte survival in articular cartilage: the influence of subchondral bone in a bovine model. J Bone Joint Surg Br 2009; 91: 691-699.
27. Sanchez C, Deberg MA, Piccardi N et al. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6,-1beta and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 2005; 13: 979-987.
28. Sanchez C, Horcajada MN, Membrez Scalfo F et al. Carnosol inhibits pro-inflammatory and catabolic mediators of cartilage breakdown in human osteoarthritic chondrocytes and mediates cross-talk between subchondral bone osteoblasts and chondrocytes. PLoS One 2015; 10: e0136118.
29. Atkins GJ, Findlay DM. Osteocyte regulation of bone mineral: A little give and take. Osteoporos Int. 2012; 23: 2067-2079.
30. Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011; 26: 229-238.
31. Ciani C, Doty SB, Fritton SP. An effective histological staining process to visualize bone interstitial fluid space using confocal microscopy. Bone 2009; 44: 1015-1017.
32. Priam S, Bougault C, Houard X et al. Identification of soluble 14-3-3 as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis. Arthritis Rheum 2013; 65: 1831-1842.
33. Torzilli PA, Bhargava M, Chen CT. Mechanical loading of articular cartilage reduces IL-1-induced enzyme expression. Cartilage 2011; 2: 364-373.
34. Yuan XL, Meng HY, Wang YC et al. Bone-cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies. Osteoarthritis Cartilage 2014; 22: 1077-1089.
35. Ludin A, Sela JJ, Schroeder A et al. Injection of vascular endothelial growth factor into knee joints induces osteoarthritis in mice. Osteoarthritis Cartilage 2013; 21: 491-497.
36. Hamilton JL, Nagao M, Levine BR et al. Targeting VEGF and its receptors for the treatment of osteoarthritis and associated pain. J Bone Miner Res 2016; 31: 911-924.
37. Oh H, Chun CH, Chun JS. Dkk-1 expression in chondrocytes inhibits experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum 2012; 64: 2568-2578.
38. Lories RJ, Corr M, Lane NE. To Wnt or not to Wnt: the bone and joint health dilemma. Nat Rev Rheumatol 2013; 9: 328-339.
39. Valverde-Franco G, Pelletier JP, Fahmi H et al. In vivo bone-specific EphB4 overexpression in mice protects both subchondral bone and cartilage during osteoarthritis. Arthritis Rheum 2012; 64: 3614-3625.
40. Matsuo K, Otaki N. Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases. Cell Adh Migr 2012; 6: 148-156.
41. Zhen G, Wen C, Jia X et al. Inhibition of TGF-signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 2013; 19: 704-712.
42. Dequeker J, Mohan S, Finkelman RD et al. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 1993; 36: 1702-1708.
43. Lotz M, Kekow J, Carson DA. Transforming growth factor-beta and cellular immune responses in synovial fluids. J Immunol 1990; 144: 4189-4194.
44. Hopwood B, Tsykin A, Findlay DM et al. Mcroarray gene expression profiling of osteoarthritic bone suggests altered bone remodeling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res Ther 2007; 9: R100.
45. Kumarasinghe DD, Sullivan T, Kuliwaba JS et al. Evidence for the dysregulated expression of TWIST1, TGF1 and SMAD3 in differentiating osteoblasts from primary hip osteoarthritis patients. Osteoarthritis Cartilage 2012; 20: 1357-1366.
46. Zhen G, Cao X. Targeting TGF signaling in subchondral bone and articular cartilage homeostasis. Trends Pharmacol Sci 2014; 35: 227-236.
47. Tang Y, Wu X, Lei W et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009; 15: 757-765.
48. Cui Z, Crane J, Xie H et al. Halofuginone attenuates osteoarthritis by inhibition of TGF-activity and H-type vessel formation in subchondral bone. Ann Rheum Dis 2015; 75: 1714-1721.
49. Xie L, Tintani F, Wang X et al. Systemic neutralization of TGF-attenuates osteoarthritis. Ann NY Acad Sci 2016 [Epub ahead of print].
50. Zhao W, Wang T, Luo Q et al. Cartilage degeneration and excessive subchondral bone formation in spontaneous osteoarthritis involves altered TGF-signaling. J Orthop Res 2016; 34: 763-770.
51. Burr DB, Gallant MA. Bone remodeling in osteoarthritis. Nat Rev Rheumatol 2012; 8: 665-673.
52. Bertuglia A, Lacourt M, Girard C et al. Osteoclasts are recruited to the subchondral bone in naturally occurring post-traumatic equine carpal osteoarthritis and may contribute to cartilage degradation. Osteoarthritis Cartilage 2016; 24: 555-566.
53. Zhang L, Hu H, Tian F et al. Enhancement of subchondral bone quality by alendronate administration for the reduction of cartilage degeneration in the early phase of experimental osteoarthritis. Clin Exp Med 2011; 11: 235-243.
54. Shirai T, Kobayashi M, Nishitani K et al. Chondroprotective effect of alendronate in a rabbit model of osteoarthritis. J Orthop Res 2011; 29: 1572-1577.
55. Hayami T, Pickarski M, Zhuo Y et al. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 2006; 38: 234-243.
56. Manicourt DH, Altman RD, Williams JM et al. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum 1999; 42: 1159-1167.
57. Kadri A, Ea HK, Bazille C et al. Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis. Arthritis Rheum 2008; 58: 2379-2386.
58. Van Offel JF, Schuerwegh AJ, Bridts CH et al. Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes. Ann Rheum Dis 2002; 61: 925-928.
59. Sondergaard BC, Madsen SH, Segovia-Silvestre T et al. Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes. BMC Musculoskelet Disord 2010; 11: 62.
60. Feng ZY, He ZN, Zhang B et al. Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. Mol Med Rep 2013; 8: 1669-1679.
61. Roos EM, Arden NK. Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol 2016; 12: 92-101.
62. Robling AG, Warden SJ, Shultz KL et al. Genetic effects on bone mechanotransduction in congenic mice harboring bone size and strength quantitative trait loci. J Bone Miner Res 2007; 22: 984-991.
63. Rai MF, Sandell LJ. Regeneration of articular cartilage in healer and non-healer mice. Matrix Biol 2014; 39: 50-55.
64. Rai MF, Sandell LJ, Zhang B et al. RNA microarray analysis of macroscopically normal articular cartilage from knees undergoing partial medial meniscectomy: potential prediction of the risk for developing osteoarthritis. PLoS One 2016; 11: e0155373.
65. Houard X, Goldring MB, Berenbaum F. Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep 2013; 15: 375.
66. Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges. Bone 2016; 85: 81-90.
67. Zhou S, Thornhill TS, Meng F et al. Influence of osteoarthritis grade on molecular signature of human cartilage. J Orthop Res 2016; 34: 454-462.
68. Upton AR, Holding CA, Dharmapatni AA et al. The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. Rheumatol Int 2012; 32: 535-540.
69. Fang J, Xu L, Li Y et al. Roles of TGF-beta 1 signaling in the development of osteoarthritis. Histol Histopathol 2016; 31: 1161-1167.
70. Xu L, Golshirazian I, Asbury BJ et al. Induction of high temperature requirement A1, a serine protease, by TGF-beta1 in articular chondrocytes of mouse models of OA. Histol Histopathol 2014; 29: 609-618.
71. Cherian JJ, Parvizi J, Bramlet D et al. Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-1 in patients with grade 3 chronic degenerative joint disease of the knee. Osteoarthritis Cartilage 2015; 23: 2109-2118.
72. Dell'accio F, De Bari C, Eltawil NM et al. Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum 2008; 58: 1410-1421.
73. Chan BY, Fuller ES, Russell AK et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage 2011; 19: 874-885.
74. Couchourel D, Aubry I, Delalandre A et al. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 2009; 60: 1438-1450.
75. Chan TF, Couchourel D, Abed E et al. Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. J Bone Miner Res 2011; 26: 1399-1410.
76. Kuliwaba JS, Findlay DM, Atkins GJ et al. Enhanced expression of osteocalcin mRNA in human osteoarthritic trabecular bone of the proximal femur is associated with decreased expression of interleukin-6 and interleukin-11 mRNA. J Bone Miner Res 2000; 15: 332-341.
77. Fazzalari NL, Kuliwaba JS, Atkins GJ et al. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J Bone Miner Res 2001; 16: 1015-1027.
78. Logar DB, Komadina R, Prezelj J et al. Expression of bone resorption genes in osteoarthritis and in osteoporosis. J Bone Miner Metab 2007; 25: 219-225.
79. Kumarasinghe DD, Perilli E, Tsangari H et al. Critical molecular regulators, histomorphometric indices and their correlations in the trabecular bone in primary hip osteoarthritis. Osteoarthritis Cartilage 2010; 18: 1337-1344.
80. Hopwood B, Gronthos S, Kuliwaba JS et al. Identification of differentially expressed genes between osteoarthritic and normal trabecular bone from the intertrochanteric region of the proximal femur using cDNA microarray analysis. Bone 2005; 36: 635-644.
81. Kumarasinghe DD, Hopwood B, Kuliwaba JS et al. An update on primary hip osteoarthritis including altered Wnt and TGF-associated gene expression from the bony component of the disease. Rheumatology (Oxford) 2011; 50: 2166-2175.
82. Sanchez-Sabate E, Alvarez L, Gil-Garay E et al. Identification of differentially expressed genes in trabecular bone from the iliac crest of osteoarthritic patients. Osteoarthritis Cartilage 2009; 17: 1106-1114.
83. Chou CH, Lee CH, Lu LS et al. Direct assessment of articular cartilage and underlying subchondral bone reveals a progressive gene expression change in human osteoarthritic knees. Osteoarthritis Cartilage 2013; 21: 450-461.
84. Zhang R, Fang H, Chen Y et al. Gene expression analyses of subchondral bone in early experimental osteoarthritis by microarray. PLoS One 2012; 7: e32356.
85. Loeser RF, Olex AL, McNulty MA et al. Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. Arthritis Rheum 2012; 64: 705-717.
86. Fazzalari N, Parkinson I. Femoral trabecular bone of osteoarthritic and normal subjects in an age and sex matched group. Osteoarthritis Cartilage 1998; 6: 377-382.
87. Jeffery AK. Osteophytes and the osteoarthritic femoral head. J Bone Joint Surg Br 1975; 57: 314-324.
88. Dall'Ara E, Ohman C, Baleani M et al. Reduced tissue hardness of trabecular bone is associated with severe osteoarthritis. J Biomech 2011; 44: 1593-1598.
89. Li B, Aspden RM. Material properties of bone from the femoral neck and calcar femorale of patients with osteoporosis or osteoarthritis. Osteoporos Int 1997; 7: 450-456.
90. Bassiouni HM. Bone marrow lesions in the knee: the clinical conundrum. Int J Rheum Dis 2010; 13: 196-202.
91. Daheshia M, Yao JQ. The bone marrow lesion in osteoarthritis. Rheumatol Int 2011; 31: 143-148.
92. Felson DT, Chaisson CE, Hill CL et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001; 134: 541-549.
93. Link TM, Steinbach LS, Ghosh S et al. Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings. Radiology 2003; 226: 373-381.
94. Garnero P, Peterfy C, Zaim S et al. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study. Arthritis Rheum 2005; 52: 2822-2829.
95. Hunter DJ, Zhang Y, Niu J et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006; 54: 1529-1535.
96. Baranyay FJ, Wang Y, Wluka AE et al. Association of bone marrow lesions with knee structures and risk factors for bone marrow lesions in the knees of clinically healthy, community-based adults. Semin Arthritis Rheum 2007; 37: 112-118.
97. Sowers MF, Hayes C, Jamadar D et al. Magnetic resonance-detected subchondral bone marrow and cartilage defect characteristics associated with pain and X-ray-defined knee osteoarthritis. Osteoarthritis Cartilage 2003; 11: 387-393.
98. Guymer E, Baranyay F, Wluka AE et al. A study of the prevalence and associations of subchondral bone marrow lesions in the knees of healthy, middle-aged women. Osteoarthritis Cartilage 2007; 15: 1437-1442.
99. Felson DT, McLaughlin S, Goggins J et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003; 139: 330-336.
100. Zhai G, Blizzard L, Srikanth V et al. Correlates of knee pain in older adults: Tasmanian Older Adult Cohort Study. Arthritis Rheum 2006; 55: 264-271.
101. Wluka AE, Wang Y, Davies-Tuck M et al. Bone marrow lesions predict progression of cartilage defects and loss of cartilage volume in healthy middle-aged adults without knee pain over 2 yrs. Rheumatology (Oxford) 2008; 47: 1392-1396.
102. Dore D, Martens A, Quinn S et al. Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults. Arthritis Res Ther 2010; 12: R222.
103. Campbell TM, Churchman SM, Gomez A. Mesenchymal stem cell alterations in bone marrow lesions in patients with hip osteoarthritis. Arthritis Rheumatol 2016; 68: 1648-1659.
104. Tanamas SK, Wluka AE, Pelletier JP et al. Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study. Rheumatology (Oxford) 2010; 49: 2413-2419.
105. Wluka AE, Teichtahl AJ, Maulana R et al. Bone marrow lesions can be subtyped into groups with different clinical outcomes using two magnetic resonance imaging (MRI) sequences. Arthritis Res Ther 2015; 17: 270.
106. Ko FC, Dragomir CL, Plumb DA et al. Progressive cell-mediated changes in articular cartilage and bone in mice are initiated by a single session of controlled cyclic compressive loading. J Orthop Res 2016 [Epub ahead of print].